Chris Sampson reviews a recent US study which looks at the cost-effectiveness of CBT versus second-generation antidepressants for the initial treatment of major depressive disorder.
[read the full story...]
Chris Sampson summarises a systematic review on the economic impact of third-wave cognitive behavioural therapies, such as mindfulness-based cognitive therapy, acceptance and commitment therapy, extended behavioural activation, dialectical behaviour therapy, and mindfulness-based stress reduction.
[read the full story...]
Chris Sampson reports on a recent systematic review and critical appraisal of economic evaluations in bipolar disorder. He finds that there’s a pressing need for new studies, especially discrete event simulations.
[read the full story...]
Elf economist Chris Sampson reports on the economic evaluation of the CoBalT RCT, which finds that CBT is cost-effective for treatment resistant depression in primary care.
[read the full story...]
In addition to its impact on quality of life, panic disorder can have a number of costly consequences such as lost productivity – particularly if also associated with agoraphobia. Cost-effectiveness is therefore an important consideration in choosing the optimal treatment for panic disorder, which might improve value via the cost side of the equation. A recent [read the full story…]
Bulimia nervosa (BN) is an eating disorder; the diagnosis of which requires: persistent preoccupation with eating and an irresistible craving for food, episodes of overeating in which large amounts of food are consumed over a short period of time and potentially attempts to counteract the “fattening” effects of food by self-induced vomiting or laxative abuse. [read the full story…]
